Jazz Pharmaceuticals, Inc.
NASDAQ: JAZZ
$106.60
+$1.14 (+1.1%)
Closing price July 10, 2020
Thursday's top analyst upgrades, downgrades and initiations included Akamai Technologies, Anheuser-Busch InBev, Boeing, BP, Comcast, Duke Energy, Gap, Kinder Morgan, Lyft, Occidental Petroleum, Snap,...
3 months ago
Last Updated: 3 months ago
Friday's top analyst upgrades, downgrades and initiations included Amazon.com, Amgen, Coca-Cola, Danaher, Electronic Arts, IBM, Proofpoint, Sprint, UPS, Uber, Vertex Pharmaceuticals and Visa.
5 months ago
Last Updated: 5 months ago
Monday's top analyst upgrades, downgrades and initiations included ADT, Altria, Biogen, Charles Schwab, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku and Wells Fargo.
7 months ago
Last Updated: 5 months ago
Monday's top analyst upgrades, downgrades and initiations included Amarin, Bank of America, Citigroup, JPMorgan, Liberty SiriusXM, Microsoft, Tesla, TripAdvisor, Twitter and Workday.
7 months ago
Last Updated: 5 months ago
Merrill Lynch research shows significant potential for upside for these stocks when the ISM manufacturing indicators rise, which signs suggest they may do in 2020.
7 months ago
Last Updated: 5 months ago
Here are three biotech stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross, plus two that went the other way.
10 months ago
Last Updated: 5 months ago
The top analyst upgrades, downgrades and initiations for Wednesday included Baidu, BP, Ciena, Chevron, Cree, Exxon Mobile, Home Depot, Medtronic, Nvidia and Urban Outfitters.
10 months ago
Last Updated: 5 months ago
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec,...
1 year ago
Last Updated: 5 months ago
Stocks were indicated up strong by almost 1% on Wednesday morning for the Dow Jones industrial average, S&P 500 and Nasdaq, quite similar to Tuesday’s gap-up open. This follows last...
1 year ago
Last Updated: 5 months ago
24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest of 2018.
1 year ago
Last Updated: 5 months ago
The top analyst upgrades, downgrades and other research calls from Wednesday include AECOM, CyberArk, Dillard's, Hasbro, Mattel, Newell, Papa John's, Shopify, Snap and Tesla.
1 year ago
Last Updated: 5 months ago
The top analyst upgrades, downgrades and other research calls from Wednesday include AT&T, Comcast, Hess, Netflix, Petrobras, Sirius XM, Texas Instruments, Verizon and Walt Disney.
1 year ago
Last Updated: 5 months ago
There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some of the best companies in the industry at rock bottom pricing.
2 years ago
Last Updated: 5 months ago
Monday’s top analyst upgrades, downgrades and initiations include AstraZeneca, Dr Pepper Snapple, Fortinet, GrubHub, Jazz Pharmaceutical and Unilever.
2 years ago
Last Updated: 5 months ago
24/7 Wall St. screened the Stifel specialty pharmaceutical list and found five stock rated Buy that have massive upside potential and probably don’t have the investment risk of some of the more...
2 years ago
Last Updated: 5 months ago